Loading...
Chemical structure of RIPK1-IN-10

GC65467

RIPK1-IN-10

Also known as N-[6-[6-[[3,5-difluoro-2-(oxan-4-yloxy)phenyl]methyl]-5-oxo-7,8-dihydro-1,6-naphthyridin-3-yl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide

RIPK1-IN-10 is a potent RIPK1 inhibitor, example 37, extracted from patent WO2021160109

ChemicalCAS2682889-51-4MW574.58FormulaC30H28F2N6O4
CAS number
2682889-51-4
Molecular weight
574.58
Formula
C30H28F2N6O4
Solubility
DMSO ： 31·25 mg/mL (54·39 mM; ultrasonic and warming and heat to 70°C)
InChIKey
WBGCAAAEJQUSDQ-UHFFFAOYSA-N
Catalogue number
GC65467
Brand
GLPBIO
Computed properties PubChem CID 156825529 · XLogP 2.5 · TPSA 111 Ų · H-bond donors 1
XLogP
2.5
TPSA
111 Ų
H-bond donors
1
H-bond acceptors
9
Rotatable bonds
7
Heavy atoms
42

SMILES C1CC1C(=O)NC2=CN3C(=N2)C=CC(=N3)C4=CC5=C(CCN(C5=O)CC6=C(C(=CC(=C6)F)F)OC7CCOCC7)N=C4

Computed descriptors from PubChem (CID 156825529), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.